Consequences of GATA-1 Deficiency in Megakaryocytes and Platelets

In the absence of the hematopoietic transcription factor GATA-1, mice develop thrombocytopenia and an increased number of megakaryocytes characterized by marked ultrastructural abnormalities. These observations establish a critical role for GATA-1 in megakaryopoiesis and raise the question as to how GATA-1 influences megakaryocyte maturation and platelet production. To begin to address this, we have performed a more detailed examination of the megakaryocytes and platelets produced in mice that lack GATA-1 in this lineage. Our analysis demonstrates that compared with their normal counterparts, GATA-1-deficient primary megakaryocytes exhibit significant hyperproliferation in liquid culture, suggesting that the megakaryocytosis seen in animals is nonreactive. Morphologically, these mutant megakaryocytes are small and show evidence of retarded nuclear and cytoplasmic development. A significant proportion of these cells do not undergo endomitosis and express markedly lower levels of mRNA of all megakaryocyte-associated genes tested, including GPIbalpha, GPIbbeta, platelet factor 4 (PF4), c-mpl, and p45 NF-E2. These results are consistent with regulation of a program of megakaryocytic differentiation by GATA-1. Bleeding times are significantly prolonged in mutant animals. GATA-1-deficient platelets show abnormal ultrastructure, reminiscent of the megakaryocytes from which they are derived, and exhibit modest but selective defects in platelet activation in response to thrombin or to the combination of adenosine diphosphate (ADP) and epinephrine. Our findings indicate that GATA-1 serves multiple functions in megakaryocyte development, influencing both cellular growth and maturation.

[1]  P. Vyas,et al.  Mice Lacking Transcription Factor NF-E2 Provide In Vivo Validation of the Proplatelet Model of Thrombocytopoiesis and Show a Platelet Production Defect That Is Intrinsic to Megakaryocytes , 1998 .

[2]  O. Nakajima,et al.  Role of GATA-1 in proliferation and differentiation of definitive erythroid and megakaryocytic cells in vivo. , 1998, Blood.

[3]  D. Seshasayee,et al.  GATA-1 Dominantly Activates a Program of Erythroid Gene Expression in Factor-Dependent Myeloid FDCW2 Cells , 1998, Molecular and Cellular Biology.

[4]  J. Dick,et al.  Enhanced Megakaryocyte and Erythroid Development From Normal Human CD34+ Cells: Consequence of Enforced Expression of SCL , 1998 .

[5]  S. Orkin,et al.  Failure of megakaryopoiesis and arrested erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOG. , 1998, Genes & development.

[6]  J. Arnold,et al.  Prolonged Bleeding Time With Defective Platelet Filopodia Formation in the Wistar Furth Rat , 1998 .

[7]  W. Vainchenker,et al.  High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice. , 1997, Blood.

[8]  L. Rangell,et al.  Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin. , 1997, Blood.

[9]  S. Orkin,et al.  Regulation of the serum concentration of thrombopoietin in thrombocytopenic NF-E2 knockout mice. , 1997, Blood.

[10]  S. Orkin,et al.  FOG, a Multitype Zinc Finger Protein, Acts as a Cofactor for Transcription Factor GATA-1 in Erythroid and Megakaryocytic Differentiation , 1997, Cell.

[11]  S. Orkin,et al.  A lineage‐selective knockout establishes the critical role of transcription factor GATA‐1 in megakaryocyte growth and platelet development , 1997, The EMBO journal.

[12]  Elaine H. Zackai,et al.  Identification of a Mutation in a GATA Binding Site of the Platelet Glycoprotein Ibβ Promoter Resulting in the Bernard-Soulier Syndrome* , 1996, The Journal of Biological Chemistry.

[13]  P. Romeo,et al.  Analysis of the thrombopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte-specific genes. , 1996, Blood.

[14]  S. Orkin,et al.  The transcriptional control of hematopoiesis. , 1996, Blood.

[15]  J. Ware,et al.  Identification of Essential GATA and Ets Binding Motifs within the Promoter of the Platelet Glycoprotein Ibα Gene (*) , 1995, The Journal of Biological Chemistry.

[16]  S. Orkin,et al.  Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[17]  K. Ault,et al.  In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in circulation. , 1995, Experimental hematology.

[18]  S. Orkin,et al.  Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoeitin/MGDF in megakaryocyte development , 1995, Cell.

[19]  T. Graf,et al.  GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. , 1995, Genes & development.

[20]  Stuart H. Orkin,et al.  Transcription Factors and Hematopoietic Development (*) , 1995, The Journal of Biological Chemistry.

[21]  K. Ravid,et al.  Characterization of regulatory elements in the 5'-flanking region of the rat GPIIb gene by studies in a primary rat marrow culture system. , 1994, Blood.

[22]  C. Disteche,et al.  Structural characterization and chromosomal location of the gene encoding human platelet glycoprotein Ibβ , 1994 .

[23]  G. Keller,et al.  Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells. , 1994, Genes & development.

[24]  J. Visvader,et al.  Megakaryocytic differentiation induced in 416B myeloid cells by GATA-2 and GATA-3 transgenes or 5-azacytidine is tightly coupled to GATA-1 expression. , 1993, Blood.

[25]  M. Hickey,et al.  Characterization of the gene encoding human platelet glycoprotein IX. , 1993, The Journal of biological chemistry.

[26]  W. Vainchenker,et al.  Expression of tal-1 and GATA-binding proteins during human hematopoiesis. , 1993, Blood.

[27]  P. Romeo,et al.  GATA and Ets cis-acting sequences mediate megakaryocyte-specific expression , 1993, Molecular and cellular biology.

[28]  J. Visvader,et al.  GATA‐1 but not SCL induces megakaryocytic differentiation in an early myeloid line. , 1992, The EMBO journal.

[29]  S. Orkin GATA-binding transcription factors in hematopoietic cells , 1992 .

[30]  K. Ravid,et al.  Transcriptional regulation of the rat platelet factor 4 gene: interaction between an enhancer/silencer domain and the GATA site , 1991, Molecular and cellular biology.

[31]  G. Uzan,et al.  Tissue-specific expression of the platelet GPIIb gene. , 1991, The Journal of biological chemistry.

[32]  T. McDonald,et al.  Thrombopoietin derived from human embryonic kidney cells stimulates an increase in DNA content of murine megakaryocytes in vivo. , 1990, Experimental hematology.

[33]  A. Look,et al.  Two-color flow cytometric measurement of DNA distributions of rat megakaryocytes in unfixed, unfractionated marrow cell suspensions. , 1984, Blood.

[34]  E. Dejana,et al.  Bleeding Time in Rats: A Comparison of Different Experimental Conditions , 1982, Thrombosis and Haemostasis.

[35]  R. Levine,et al.  Isolation of intact megakaryocytes from guinea pig femoral marrow. Successful harvest made possible with inhibitions of platelet aggregation; enrichment achieved with a two-step separation technique , 1976, The Journal of cell biology.

[36]  A Krishan,et al.  Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining , 1975, The Journal of cell biology.

[37]  C. Jackson Cholinesterase as a possible marker for early cells of the megakaryocytic series. , 1973, Blood.

[38]  C. L. Brown,et al.  Genetic control of platelet activation in inbred mouse strains. , 1997, Platelets.

[39]  S. Orkin,et al.  Development of hematopoietic cells lacking transcription factor GATA-1. , 1995, Development.

[40]  F. Gardner,et al.  Use of mean platelet volume improves detection of platelet disorders. , 1985, Blood cells.